Gelteq (GELS) Receivables - Other (2023 - 2025)

Gelteq's (GELS) quarterly Receivables - Other came in at $250281.3 in Q2 2025, up 165.0% year-on-year from $94446.8 in Q2 2024, and up 165.0% quarter-over-quarter from $94446.8 in Q2 2024.

Gelteq (GELS) Receivables - Other (2023 - 2025) Analysis & Trends

Gelteq's Receivables - Other history runs 3 years deep, the most recent figure standing at $250281.3 for Q2 2025.

  • On a quarterly basis, Receivables - Other rose 165.0% year-over-year to $250281.3 in Q2 2025; TTM through Jun 2025 was $250281.3, a 165.0% increase from a year earlier, with the FY2025 full-year figure at $250281.3, up 165.0% from the prior year.
  • Receivables - Other climbed to $250281.3 in Q2 2025 per GELS's latest filing, from $94446.8 in the prior quarter.
  • Across five years, Receivables - Other topped out at $250281.3 in Q2 2025 and bottomed at $94446.8 in Q2 2024.
  • The 3-year median for Receivables - Other is $175816.9 (2023), against an average of $173515.0.
  • Across the five-year window, Receivables - Other plunged 46.28% in 2024 and soared 165.0% in 2025, its largest moves.
  • Year by year, Receivables - Other stood at $175816.9 in 2023, then tumbled by 46.28% to $94446.8 in 2024, then jumped by 165.0% to $250281.3 in 2025.
  • Per Business Quant, the three latest GELS Receivables - Other figures stand at $250281.3 (Q2 2025), $94446.8 (Q2 2024), and $175816.9 (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Gelteq 740.00 -47,821.64 -

Historic Data

Download Data
DateValue
Jun 30, 2025 250,281.30
Jun 30, 2025 250,281.30
Jun 30, 2024 94,446.78
Jun 30, 2024 94,446.78
Jun 30, 2023 175,816.89
Jun 30, 2023 175,816.89